Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$164,075
New position
Shares Held
44,465
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 72 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 50%
Shared 50%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TUDOR INVESTMENT CORP ET AL holds $64,629,641 across 19 Drug Manufacturers - Specialty & Generic names. ALVO ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
490,000 | $16,601,200 | |
| 2 | ZTS |
Zoetis Inc.
|
208,246 | $14,964,557 | |
| 3 | HLN |
Haleon plc
|
762,877 | $7,117,642 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
12,667 | $6,863,360 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
256,108 | $6,302,817 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
128,796 | $4,465,357 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
195,128 | $1,951,280 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
100,149 | $1,605,388 |
All Filings in ALVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,075 | 44,465 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||